Cover Image
Market Research Report

Pharma Wholesale and Distribution Market Forecasts 2018-2028: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW

Published by Visiongain Ltd Product code 247784
Published Content info 277 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pharma Wholesale and Distribution Market Forecasts 2018-2028: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW
Published: November 6, 2018 Content info: 277 Pages
Description

The pharma wholesale and distribution market is estimated to grow at a CAGR of 5.6% in the first half of the forecast period. The market is estimated to reach a revenue of $1.3bn in 2023. In 2017, the branded drugs submarket held 79% of the pharma wholesale and distribution market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 277-page report you will receive 93 tables and 107 figures- all unavailable elsewhere.

The 277-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pharma Wholesale and Distribution Market from 2018-2028

Forecast of the Global Pharma Wholesale and Distribution market by Category:

  • Generic Drugs
  • Branded Drugs
  • Others

This report provides individual revenue forecasts to 2028 for these national markets:

  • US
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Japan
  • China
  • Brazil
  • India
  • Russia
  • RoW

Each National Market is further segmented into generic drugs, branded drugs and others

Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:

  • Alfresa Holdings
  • AmerisourceBergen
  • Cardinal Health
  • McKesson
  • Medipal
  • PHOENIX Group
  • Shanghai Pharma
  • SINOPHARM
  • Suzuken
  • Walgreens Boots Alliance

This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.

Visiongain's study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.

Buy our report today Pharma Wholesale and Distribution Market Forecasts 2018-2028: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW’.

Visiongain is a trading partner with the US Federal Government.

Table of Contents
Product Code: PHA0339

Table of Contents

1. Report Overview

  • 1.1 Global Pharma Wholesale and Distribution Industry and Market Overview
  • 1.2 Benefits of This Report
  • 1.3 How This Report Delivers
  • 1.4 Questions Answered by This Analytical Report
  • 1.5 Who is This Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Pharma Wholesale and Distribution

  • 2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
    • 2.1.1 Full-Line Wholesalers (FLWs)
    • 2.1.2 Short-Line Wholesalers (SLWs)
  • 2.2 The Chain of Distribution: Wholesalers vs. Logistic Service Providers
    • 2.2.1 Secondary Wholesalers
    • 2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
    • 2.2.3 Major Wholesalers: Distribution of a Large Number of Products to Generate High Profits
    • 2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
    • 2.2.5 Pharmacy Benefit Managers
  • 2.3 Generative Revenue and Profit
    • 2.3.1 Forward Buying to Avoid Price Increases
    • 2.3.2 Fee-for-Service: A Clear Pricing Structure
      • 2.3.2.1 Inventory Management Agreements
    • 2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
    • 2.3.4 Reimbursement and Wholesalers
    • 2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
    • 2.3.6 Parallel Trade: Different Attitudes in Europe and the US

3. The World Pharmaceutical Wholesale and Distribution Market: 2017-2028

  • 3.1 The World Pharmaceutical Wholesale and Distribution Market in 2017, Restricted by Government Price Reductions and Generic Substitution
  • 3.2 The Pharmaceutical Wholesale and Distribution Industry: World Market Forecast, 2017-2028
  • 3.3 Branded and Generic Drugs: Revenue vs. Profit, 2017-2028
    • 3.3.1 Branded and Generic Drugs: Revenue Generation, 2017
    • 3.3.2 Branded Drugs: Revenue Forecast, 2017-2028
    • 3.3.3 Generic Drugs: Revenue Forecast, 2017-2028

4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2017-2028

  • 4.1 The Leading National Markets: the US Dominates in 2017
  • 4.2 The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
  • 4.3 The US Pharma Wholesale and Distribution Market
    • 4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
    • 4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
    • 4.3.3 An Increase in Fee-For-Service Activity
    • 4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2017-2028
  • 4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
    • 4.4.1 The Difference Between the US and European Markets
    • 4.4.2 State-Funded Healthcare and Reimbursement
    • 4.4.3 EU5: Market Forecast, 2017-2028
    • 4.4.4 Germany: Pharma Wholesale and Distribution Market, 2017
      • 4.4.4.1 Healthcare Reform
      • 4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
      • 4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2017-2028
    • 4.4.5 France: Pharma Wholesale and Distribution Market, 2017
      • 4.4.5.1 France: Social Security Finance Bill 2015
      • 4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2017-2028
    • 4.4.6 Italy: Pharma Wholesale and Distribution Market, 2017
      • 4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2017-2028
    • 4.4.7 Spain: Pharma Wholesale and Distribution Market, 2017
      • 4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2017-2028
    • 4.4.8 UK: Pharma Wholesale and Distribution Market, 2017
      • 4.4.8.1 Price Cuts in the UK
      • 4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2017-2028
  • 4.5 Japan: Pharma Wholesale and Distribution Market, 2017
    • 4.5.1 Drug Pricing and Performing Fees in Japan
    • 4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2017-2028
  • 4.6 China: Pharma Wholesale and Distribution Market, 2017
    • 4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2017
    • 4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2017-2028
  • 4.7 Brazil: Pharma and Wholesale Distribution Market, 2017
    • 4.7.1 Drug Price Controls in Brazil
    • 4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2017
    • 4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2017-2028
  • 4.8 India: Pharma Wholesale and Distribution Market, 2017
    • 4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2017-2028
  • 4.9 Russia: Pharma Wholesale and Distribution Market, 2016
    • 4.9.1 Drug Pricing Controls in Russia
    • 4.9.2 Market Trends in Russia
    • 4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2017-2028
  • 4.10 Conclusion

5. Leading Pharma Wholesalers and Distributors In 2016: Current and Future Performance

  • 5.1 The Leading Pharma Wholesalers and Distribution Companies in 2017
  • 5.2 Revenue vs. Profit
  • 5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2017-2028
  • 5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
    • 5.4.1 McKesson: Historical Performance, 2011-2016
    • 5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
    • 5.4.3 McKesson: Revenue Forecast, 2017-2028
  • 5.5 Cardinal Health: The World's Third Largest Pharma Wholesaler
    • 5.5.1 Cardinal Health: Historical Performance, 2011-2016
    • 5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
    • 5.5.3 Cardinal Health: Revenue Forecast, 2017-2028
  • 5.6 AmerisourceBergen: Third Largest Global Pharma Wholesaler and Distributor
    • 5.6.1 AmerisourceBergen: Historical Performance, 2016
    • 5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
    • 5.6.3 AmerisourceBergen: Revenue Forecast, 2017-2028
  • 5.7 Walgreens Boots Alliance: The Largest Drugstore Chain in the US and Global Wholesale and Distribution Network
    • 5.7.1 Walgreens Boots Alliance: Historical Performance, 2011-2016
    • 5.7.2 Acquisitions and Future Strategies of Walgreens Boots Alliance
    • 5.7.3 Walgreens Boots Alliance: Revenue Forecast, 2017-2028
  • 5.8 MEDIPAL HOLDINGS CORPORATION: Japan's Leading Pharmaceutical Wholesaler
    • 5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2011-2016
    • 5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
    • 5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2017-2028
  • 5.9 Phoenix Group: Biggest European Wholesalers
    • 5.9.1 The PHOENIX Group: Historical Performance, 2011-2016
    • 5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisition
    • 5.9.3 The PHOENIX Group: Revenue Forecast, 2017-2028
  • 5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
    • 5.10.1 SINOPHARM: Historical Performance, 2011-2016
    • 5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
    • 5.10.3 SINOPHARM: Revenue Forecast, 2017-2028
  • 5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
    • 5.11.1 Alfresa Holdings: Historical Performance, 2011-2016
    • 5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
    • 5.11.3 Alfresa Holdings: Revenue Forecast, 2017-2028
  • 5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
    • 5.12.1 SUZUKEN CO. LTD: Historical Performance, 2011-2016
    • 5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
    • 5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2017-2028
  • 5.13 Shanghai Pharmaceuticals Holding: China's Second Largest Wholesaler
    • 5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2011-2016
    • 5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
    • 5.13.3 Shanghai Pharma: Revenue Forecast, 2017-2028

6. Qualitative Analysis of the Pharma Wholesale and Distribution Market

  • 6.1 The Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2017
    • 6.1.1 The Insatiable Demand for Drugs: A Recession Proof Industry?
    • 6.1.2 Wholesalers Do More than Deliver Drugs
      • 6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
      • 6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
    • 6.1.3 Large Companies Dominate the Market
    • 6.1.4 Despite High Revenues, Profit Margins Are Low
    • 6.1.5 Government-Induced Drug Price Pressures Restrict Profits
    • 6.1.6 The Problem of Counterfeit Drugs
  • 6.2 The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2017-2028
    • 6.2.1 The Demand for Pharmaceuticals is Increasing
    • 6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
    • 6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue but Drive Profit Generation
    • 6.2.4 The Promotion of Drug Therapy in the US
    • 6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
    • 6.2.6 Increased Adoption of the DTP Distribution Model
      • 6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
      • 6.2.6.2 DTP in the UK Since 1991
      • 6.2.6.3 DTP in Poland: The Second European Country To Adopt the DTP Model
      • 6.2.6.4 Further Expansion of the DTP Model
    • 6.2.7 The Threat of Healthcare Budget Cuts
      • 6.2.7.1 Healthcare Budget Cuts in Germany
      • 6.2.7.2 Healthcare Budget Cuts in France
      • 6.2.7.3 Healthcare Budget Cuts in Italy
      • 6.2.7.4 Healthcare Budget Cuts in Spain
      • 6.2.7.5 Healthcare Budget Cuts in the UK
    • 6.2.8 Do Large Pharmacy Chains Pose a Threat?
      • 6.2.8.1 Case Study: Walmart and the $4 Prescription Scheme
      • 6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
    • 6.2.9 Does the Diversion and Re-Importation of Medicines Pose a Threat to the Industry?
    • 6.2.10 The Threat of Industry Consolidation
  • 6.3 Social, Technological, Economic and Political Factors Influencing the Market, 2017-2028 (STEP Analysis)
    • 6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
    • 6.3.2 Political Factor: Combating Counterfeit Medicines
      • 6.3.2.1 The US and E-Pedigree: Becoming Law in California
      • 6.3.2.2 European Pedigree Legislation
      • 6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
      • 6.3.2.4 Serialisation for Wholesalers: Opportunity or a Challenge?

7. Conclusions

  • 7.1 The Future of the Pharma Wholesale and Distribution Market
  • 7.2 The Leading National Pharma Wholesale and Distribution Markets
  • 7.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
  • 7.4 Trends in the Pharma Wholesale and Distribution Industry
    • 7.4.1 Generics Will Threaten Revenue
    • 7.4.2 Manufacturers Will Deliver More Drugs Directly
    • 7.4.3 There Will Be Greater Demand for Specialty Medicines
    • 7.4.4 Consolidation Will Drive Growth
    • 7.4.5 Anti-Counterfeiting Demands Will Add to Wholesalers' Costs
  • Appendices
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 2.1 Use of DTP Model in the UK, 2007-2012
  • Table 3.1 Pharmaceutical Wholesale and Distribution: World Market Forecast ($bn), AGR (%), CAGR (%), 2017-2028
  • Table 3.2 Pharmaceutical Wholesale and Distribution: Branded Drugs, Generic Drugs and Others, Revenue ($bn) Forecasts, AGR (%), CAGR (%) and Market Shares (%), 2017-2028
  • Table 3.3 Wholesale and Distribution of Branded Drugs: Revenue ($bn) and Market Share (%) Forecast, 2017-2028
  • Table 3.4 Wholesale and Distribution of Generic Drugs: Revenue ($bn) and Market Share (%) Forecast, 2017-2028
  • Table 4.1 Pharma Wholesale & Distribution Leading National Markets: Revenues ($bn) and Market Share (%), 2017
  • Table 4.2 Pharma Wholesale & Distribution Leading National Markets: Revenue ($bn) Forecasts, AGR (%) and CAGR (%), 2017-2028
  • Table 4.3 US Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.4 Us Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) And CAGR (%), 2017-2028
  • Table 4.5 Price Controls in Europe, 2016
  • Table 4.6 EU5 Pharma Wholesale & Distribution Market: Revenue ($bn) Forecasts, AGR (%) and CAGR (%), 2017-2028
  • Table 4.7 German Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.8 German Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.9 French Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.10 French Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.11 Italian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.12 Italian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.13 Spanish Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.14 Spanish Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.15 UK Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.16 UK Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.17 Percentage of The Population Ages 60+ In the Us, Europe, Japan, China and India, 2015 And 2030
  • Table 4.18 Japanese Pharmaceutical Wholesale and Distribution Market: Drug Price Revision Growth (%), 2007-2017
  • Table 4.19 Japanese Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.20 Japanese Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.21 Chinese Pharma Wholesale & Distribution: Revenue ($bn) And Market Shares (%) of Leading Companies, 2017
  • Table 4.22 Chinese Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.23 Chinese Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.24 Brazilian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.25 Brazilian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.26 Indian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.27 Indian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.28 Russian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 4.29 Russian Pharma Wholesale & Distribution Market: Revenue ($Bn) Forecast, AGR (%) and CAGR (%), 2017-2028
  • Table 5.1 Leading Companies in The Pharmaceutical Wholesale and Distribution Market: Revenues ($bn) and Market Shares (%), 2017
  • Table 5.2 Leading Pharmaceutical Wholesale and Distribution Companies: Revenue Forecasts ($bn), AGR (%) and CAGR (%), 2017-2028
  • Table 5.3 Leading Pharmaceutical Wholesale and Distribution Companies: Market Shares (%) for 2017, 2022 And 2028
  • Table 5.4 Mckesson, Distribution Solutions: Services and Customers, 2017
  • Table 5.5 Mckesson, Technology Solutions: Services and Customers, 2017
  • Table 5.6 Mckesson: Historical Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit ($bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.7 Mckesson: Revenue ($bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.8 Mckesson: Gross Profit ($bn), Gross Profit Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.9 Acquisitions by Mckesson, 2007-2018
  • Table 5.10 Mckesson: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.11 Cardinal Health: Historical Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Operating Earnings ($bn), AGR (%) and CAGR (%), 2010-2015
  • Table 5.12 Cardinal Health: Revenue ($bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.13 Cardinal Health: Operating Earnings ($bn) and Annual Growth (%) Breakdown by Business Segment, 2016-2017
  • Table 5.14 Cardinal Health: Revenue ($bn) And Revenue Share (%) Breakdown by Customer, 2017
  • Table 5.15 Selected Acquisitions by Cardinal Health and Their Line of Business, 2007-2018
  • Table 5.16 Cardinal Health: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.17 Amerisourcebergen: Historical Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit ($bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.18 Amerisourcebergen: Revenue ($bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.19 Amerisourcebergen: Gross Profit ($bn), Gross Profit Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.20 Amerisourcebergen: Revenue ($bn) and Revenue Share (%) Breakdown by Customer, 2017
  • Table 5.21 Acquisitions by Amerisourcebergen and Their Line of Business, 2007-2018
  • Table 5.22 Amerisourcebergen: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.23 Walgreens Boots Alliance: Revenue ($bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit ($bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.24 Walgreens Boots Alliance: Pharmaceutical Wholesale Revenue ($bn), AGR (%), and CAGR (%) Forecast, 2017-2028
  • Table 5.25 Medipal Holdings: Consolidated Subsidiary Companies, 2017
  • Table 5.26 Medipal Holdings: Historical Revenue (¥bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (¥bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.27 Medipal Holdings: Revenue (¥bn, $bn) and Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.28 Medipal Holdings: Operating Income ($bn, ¥bn), Operating Income Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.29 Medipal Holdings: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.30 Phoenix Group: Subsidiary Companies, 2017
  • Table 5.31 Phoenix Group: Historical Revenue (€bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (€bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.32 Phoenix Group: Revenue (€bn, $bn), Revenue Share (%) Breakdown by Region, 2017
  • Table 5.33 Phoenix Group: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.34 Sinopharm Group: Historical Revenue (RMBbn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (RMBbn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.35 Sinopharm Group: Revenue (RMBbn, $bn) and Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.36 Sinopharm Group: Operating Profit (RMBbn, $bn), Operating Profit Share (%) and AGR (%) Breakdown by Business Segment, 2015-2016
  • Table 5.37 Sinopharm Group: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.38 Alfresa Holdings: List of Significant Subsidiaries and Affiliates, 2017
  • Table 5.39 Alfresa Holdings: Historical Revenue (¥bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (¥bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.40 Alfresa Holdings: Business Strategies, 2013-2017
  • Table 5.41 Alfresa Holdings: Revenue (¥bn, $bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.42 Alfresa Holdings: Gross Profit (¥bn, $bn), Gross Profit Share (%) and AGR (%) Breakdown by Business Segment, 2016-2017
  • Table 5.43 Alfresa Holdings: Challenges for the 16-18 Mid-Term Management Plan - Break Through to Tomorrow, 2016
  • Table 5.44 Alfresa Holdings: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.45 Suzuken: Historical Revenue (¥bn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (¥bn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.46 Suzuken: Revenue (¥bn, $bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2015-2016
  • Table 5.47 Suzuken: Operating Income (¥bn, $bn), Operating Income Share (%) and AGR (%) Breakdown by Business Segment, 2015-2016
  • Table 5.48 Suzuken: Revenue (¥bn, $bn), Revenue Share (%) Breakdown for Pharmaceuticals Distribution Segment by Region, 2014
  • Table 5.49 Suzuken: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 5.50 Shanghai Pharmaceuticals Holding: Historical Revenue (RMBbn, $bn), Revenue AGR (%), Revenue CAGR (%), Gross Profit (RMBbn, $bn), Gross Profit AGR (%) and Gross Profit CAGR (%), 2011-2016
  • Table 5.51 Shanghai Pharmaceuticals Holding: Revenue (RMBbn, $bn), Revenue Share (%) and AGR (%) Breakdown by Business Segment, 2015-2016
  • Table 5.52 Shanghai Pharmaceuticals Holding: Operating Profit (RMBbn, $bn), Operating Profit Share (%) and AGR (%) Breakdown by Business Segment, 2015-2016
  • Table 5.53 Shanghai Pharmaceuticals Holding: Distribution Revenue (RMBbn, $bn), Distribution Revenue Share (%) Breakdown by Region, 2016
  • Table 5.54 Shanghai Pharmaceuticals Holding: Revenue ($bn), AGR (%) and CAGR (%) Forecast, 2017-2028
  • Table 6.1 The Pharmaceutical W&D Market: Strengths and Weaknesses, 2017
  • Table 6.2 The Pharmaceutical W&D Market: Opportunities and Threats, 2017-2028
  • Table 6.3 Strengths and Weaknesses of The DTP Distribution Model, 2017
  • Table 6.4 ITR Ratings and Corresponding Reimbursement Rates, 2017
  • Table 6.5 Social, Technological, Economic and Political Factors Influencing the Pharmaceutical Wholesale and Distribution Market (Step Analysis), 2017-2028

List of Figures

  • Figure 2.1 Routes of Drug Distribution, 2017
  • Figure 3.1 The Global Pharmaceutical Wholesale and Distribution Market: Drivers and Restraints, 2017
  • Figure 3.2 Pharmaceutical Wholesale and Distribution: World Market Forecast ($Bn), 2017-2028
  • Figure 3.3 Branded Drugs, Generic Drugs and Others: Market Shares (%), 2017
  • Figure 3.4 Pharmaceutical Wholesale and Distribution: World Market Forecast ($Bn) By Category, 2017-2028
  • Figure 3.5 Branded Drugs, Generic Drugs and Others: Market Shares (%), 2023
  • Figure 3.6 Branded Drugs, Generic Drugs and Others: Market Shares (%), 2028
  • Figure 3.7 Wholesale and Distribution of Branded Drugs, Generic Drugs and Others: Revenue Forecasts ($bn), 2017-2028
  • Figure 3.8 Wholesale and Distribution of Branded Drugs: Revenue ($bn) Forecast, 2017-2028
  • Figure 3.9 Wholesale and Distribution of Generic Drugs: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.1 Pharma Wholesale & Distribution Leading National Markets: Shares (%), 2017
  • Figure 4.2 Pharma Wholesale & Distribution Leading National Markets: Shares (%), 2023
  • Figure 4.3 Pharma Wholesale & Distribution Leading National Markets: Shares (%), 2028
  • Figure 4.4 Market Share (%) Breakdown of The Us Market: The 3 Leading Companies, 2017
  • Figure 4.5 US Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.6 US Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.7 US Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.8 EU5 Pharma Wholesale & Distribution Market Shares (%), 2017, 2023 And 2028
  • Figure 4.9 EU5 Pharma Wholesale & Distribution Market: Revenue ($bn) Forecasts, 2017-2028
  • Figure 4.10 EU Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.11 German Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.12 German Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($Bn) Forecast, 2017-2028
  • Figure 4.13 German Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.14 French Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.15 French Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.16 French Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.17 Italian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.18 Italian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.19 Italian Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.20 Spanish Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.21 Spanish Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.22 Spanish Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.23 UK Pharma Wholesale & Distribution Market: Revenue ($bn), 2017-2028
  • Figure 4.24 UK Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.25 UK Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.26 Percentage of The Population Ages 65+ in the Us, Europe, Japan, China and India, 2015 And 2030
  • Figure 4.27 Japanese Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.28 Japanese Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.29 Japanese Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.30 Chinese Pharma Wholesale & Distribution: Market Shares (%) of Leading Companies, 2017
  • Figure 4.31 Chinese Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.32 Chinese Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.33 Chinese Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.34 Brazilian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.35 Brazilian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.36 Brazilian Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.37 Pharma Wholesale & Distribution Model in India, 2017
  • Figure 4.38 Indian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.39 Indian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.40 Indian Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 4.41 Russian Pharma Wholesale & Distribution Market: Revenue ($bn) Forecast, 2017-2028
  • Figure 4.42 Russian Pharma Wholesale & Distribution Market by Drugs Category: Revenue ($Bn) Forecast, 2017-2028
  • Figure 4.43 Russian Pharma Wholesale & Distribution Market: Drivers and Restraints, 2017
  • Figure 5.1 Leading Pharmaceutical Wholesale and Distribution Companies: Market Shares (%), 2017
  • Figure 5.2 Leading Pharmaceutical Wholesale and Distribution Companies: Market Shares (%), 2023
  • Figure 5.3 Leading Pharmaceutical Wholesale and Distribution Companies: Market Shares (%), 2028
  • Figure 5.4 Leading Pharmaceutical W&D Companies: Drivers and Restraints, 2017
  • Figure 5.5 Mckesson: Historical Revenue ($bn), Revenue AGR (%), Gross Profit ($bn) And Gross Profit AGR (%), 2011-2016
  • Figure 5.6 Mckesson: Revenue Share (%) Breakdown by Business Segment, 2016
  • Figure 5.7 Mckesson: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 5.8 Mckesson: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.9 Mckesson: Drivers and Restraints, 2017
  • Figure 5.10 Cardinal Health: Historical Revenue ($bn), Revenue AGR (%), Operating Earnings ($bn) and Operating Earnings AGR (%), 2011-2016
  • Figure 5.11 Cardinal Health: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 5.12 Cardinal Health: Revenue Share (%) Breakdown by Customer, 2017
  • Figure 5.13 Cardinal Health: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.14 Cardinal Health: Drivers and Restraints, 2017-2028
  • Figure 5.15 Amerisourcebergen: Historical Revenue ($bn), Revenue AGR (%), Gross Profit ($bn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.16 Amerisourcebergen: Revenue Share (%) Breakdown by Business Segment, 2017
  • Figure 5.17 Amerisourcebergen: Revenue ($bn) Breakdown by Customer, 2017
  • Figure 5.18 Amerisourcebergen: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.19 Amerisourcebergen: Drivers and Restraints, 2017
  • Figure 5.20 Walgreens Boots Alliance: Revenue ($bn), Revenue AGR (%), Gross Profit ($bn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.21 Walgreens Boots Alliance: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.22 Alliance Boots: Drivers and Restraints, 2017-2028
  • Figure 5.23 Medipal Holdings: Historical Revenue (¥bn), Revenue AGR (%), Gross Profit (¥bn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.24 Medipal Holdings: Revenue Share (%) Breakdown by Business Segment, 2016
  • Figure 5.25 Medipal Holdings: Operating Income Share (%) Breakdown by Business Segment, 2017
  • Figure 5.26 Medipal Holdings: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.27 Medipal Holdings: Drivers and Restraints, 2017
  • Figure 5.28 Phoenix Group: Historical Revenue (€bn), Revenue AGR (%), Gross Profit (€bn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.29 Phoenix Group: Revenue Share (%) Breakdown by Region, 2014
  • Figure 5.30 Phoenix Group: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.31 Phoenix Group Drivers and Restraints, 2017
  • Figure 5.32 Sinopharm Group: Historical Revenue (RMBbn), Revenue AGR (%), Gross Profit (RMBbn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.33 Sinopharm Group: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.34 Sinopharm Group: Drivers and Restraints, 2017
  • Figure 5.35 Alfresa Holdings: Historical Revenue (¥bn), Revenue AGR (%), Gross Profit (¥bn), Gross Profit AGR (%), 2011-2016
  • Figure 5.36 Alfresa Holdings: Revenue Share (%) Breakdown by Business Segment, 2016
  • Figure 5.37 Alfresa Holdings: Gross Profit Share (%) Breakdown by Business Segment, 2017
  • Figure 5.38 Alfresa Holdings: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.39 Alfresa Holdings: Drivers and Restraints, 2017
  • Figure 5.40 Suzuken: Historical Revenue (¥bn), Revenue AGR (%), Gross Profit (¥bn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.41 Suzuken: Revenue Share (%) Breakdown by Business Segment, 2015
  • Figure 5.42 Suzuken: Operating Income Share (%) Breakdown by Business Segment, 2016
  • Figure 5.43 Suzuken: Revenue Share (%) Breakdown by Region in Japan, 2014
  • Figure 5.44 Suzuken: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.45 Suzuken: Drivers and Restraints, 2017
  • Figure 5.46 Shanghai Pharmaceuticals Holding: Historical Revenue (RMBbn), Revenue AGR (%), Gross Profit (RMBbn) and Gross Profit AGR (%), 2011-2016
  • Figure 5.47 Shanghai Pharmaceuticals Holding: Revenue Share (%) Breakdown by Business Segment, 2016
  • Figure 5.48 Shanghai Pharmaceuticals Holding: Revenue Share (%) Breakdown by Region, 2016
  • Figure 5.49 Shanghai Pharmaceuticals Holding: Revenue ($bn) Forecast, 2017-2028
  • Figure 5.50 Shanghai Pharmaceuticals Holding: Drivers and Restraints, 2017
  • Figure 6.1 Comparison of The Wholesale and DTP Routes of Distribution, 2017
  • Figure 7.1 Pharmaceutical Wholesale and Distribution: Global Market Forecasts ($Bn) By Submarket, 2017-2028
  • Figure 7.2 Leading National Pharmaceutical Wholesale and Distribution Markets: Revenue Projections ($Bn), 2017, 2022 And 2028
  • Figure 7.3 Leading Pharmaceutical Wholesale and Distribution Companies: Revenue ($Bn) Projections 2017, 2022 And 2028

COMPANIES LISTED:

  • 36.6
  • AAH Pharmaceuticals
  • AccessClosure
  • Acofarma (Asociación Cooperativas Farmacéuticas)
  • ADG Apotheken-Dienstleistungsgesellschaft mbH
  • Admenta
  • Alfresa Fine Chemical Corporation
  • Alfresa Holdings
  • Alliance Boots
  • Alliance Healthcare
  • Alliance Santé
  • Alliance UniChem
  • AmeriSource Health
  • AmerisourceBergen
  • AmerisourceBergen Canada
  • AmerisourceBergen Drug Corporation (ABDC)
  • AmerisourceBergen specialty Group (ABSG)
  • Apollo Medical Holdings
  • ASTEC Co., Ltd.
  • ASTIS Co., Ltd.
  • Athos Farma
  • ATOL CO., LTD.
  • Azwell
  • Bayer
  • BENU Apotheek
  • Bergen Brunswig
  • Biologics Inc
  • Boots Group
  • Bristol-Myers Squibb
  • Brocacef Groep NV
  • Brocacef Holding
  • Bundesverband des Pharmazeutischen Grosshandel
  • Cardinal Health
  • Caremark Rx
  • Celesio AG
  • CERP Bretagne Nord
  • CERP Rhin Rhone Mediterranee
  • CERP Rouen
  • Chiyaku Co
  • Chuounyu Co., Ltd.
  • Cloumed Corporation
  • Cofares
  • Comifar
  • Cordis
  • CoverMyMeds
  • CoverMyMeds LLC
  • CVS Caremark
  • CVS Corporation
  • CVS Health Corporation
  • Cystic Fibrosis Foundation Pharmacy, LLC
  • Daiichi Sankyo Propharma Co.
  • Dong Ying (Jiangsu) Pharmaceuticals Co., Ltd.
  • Drogarias Tamoio
  • Drug Trading Company Ltd
  • Dutch ACM
  • Emart Company
  • ENSHU YAKUHIN CO., LTD.
  • Ethicon
  • EVERLTH AGROTECH Co., Ltd.
  • EVERLTH Co., Ltd.
  • Farcopa Distribuzione
  • Fukujin Co.
  • Good Service Co
  • Guangzhou Pharmaceutical Company Ltd.
  • Guangzhou Pharmaceuticals Corporation
  • Harvard Drug
  • Hedef Alliance
  • Hefame
  • HEISEI YAKUHIN CO., LTD.
  • IZUTSU KURAYA SANSEIDO Inc.
  • IZUTSU PHARMACEUTICAL CO. LTD.
  • Japanese Pharmaceutical Wholesalers Association
  • Jingu Yakuhin Co., Ltd.
  • Johnson & Johnson
  • Katren
  • Kenzmedico Co., Ltd.
  • Kerr Drug
  • KOBASHOU. CO., LTD.
  • KURAYA SANSEIDO Inc
  • Life Medicom Co., Ltd.
  • Lloyds Pharmacy
  • MARUZEN YAKUHIN CO., LTD.
  • McKesson
  • McQueary Brothers of Springfield
  • Medical Specialties Distributors
  • MEDICEO CORPORATION
  • Medicine Shoppe Canada Inc.
  • MEDIE Co., Ltd.
  • MEDIPAL HOLDINGS CORPORATION
  • Mediq Apotheken Nederland B.V.
  • Medtronic
  • Meinan Distribution Center
  • Metro Medical Supply Inc
  • Mitsubishi
  • MM CORPORATION
  • MP AGRO CO., LTD.
  • MVC CO., LTD
  • MWI Veterinary Supply, Inc.
  • Nadro
  • Nakano Yakuhin Co., Ltd.
  • National Health Service (NHS)
  • National Pharmaceutical Pricing Authority (NPPA)
  • Nihon Apoch Co.
  • Novo Nordisk
  • Novodata Zrt.
  • Numark
  • OCP
  • Oncology Therapeutics
  • Oncoprod
  • OptumRx
  • P.J.D. Network
  • PALTAC CORPORATION
  • Paltac Corporation
  • Paltac Corporation
  • PALTAC KS CORPORATION
  • Panpharma
  • Pfercos Co., Ltd.
  • Pfizer
  • PharMEDium
  • Polska Grupa Farmaceutyczna
  • Profarma
  • Prosper
  • Protek
  • PSC Co, Ltd.
  • PSS World Medical Inc.
  • Ratiopharm
  • RDC Kanto5
  • Red Oak Sourcing
  • Red Oak, LLC
  • Rexall Health
  • Rite Aid Corporation
  • Rosta
  • RxCrossroads
  • S. D.Collabo Co.,Ltd.
  • S.D.Logi CO., Ltd.
  • Sakurai Tsusho Corporation
  • Sanacorp
  • Sandoz
  • Sanki Corporation
  • Sanki MediHeart Limited
  • Sanki Wellbe
  • Sanki Wellbe Co., Ltd.
  • Sannova
  • Sanwa Kagaku Kenkyusho Co., Ltd.
  • S-Care Mate Co., Ltd.
  • Sciclone Trade
  • SEIWA SANGYO CO
  • Shanghai Fosun Pharmaceutical
  • Shanghai Pharma Zhenjiang Co., Ltd.
  • Shanghai Pharmaceutical Holdings
  • Shinohara Chemicals
  • Shinsegai Group
  • Shoyaku Co., Ltd.
  • SIA International
  • Sincamesp
  • SINOPHARM
  • S-mile, Inc
  • Sonexus Health
  • SPH Jiangxi Shangrao Pharmaceutical Co., Ltd.
  • SPH Keyuan Xinhai Pharmaceutical Hebei Co., Ltd.
  • SPH Keyuan Xinhai Pharmaceutical Heilongjiang Co., Ltd.
  • SPLine Corporation
  • SUZUKEN
  • Suzuken Co., Ltd.
  • Suzuken Iwate Co., Ltd.
  • Suzuken Medical Instruments Co, Ltd
  • Suzuken Okinawa Yakuhin Co., Ltd.
  • The PHOENIX Group
  • Toho Holdings
  • Tokiwa Yakuhin Co
  • Torfarm
  • Tradex International
  • TS Alfresa Corporation
  • UniChem
  • US Oncology Holdings, Inc.
  • USHIODA KURAYA SANSEIDO Inc.
  • USHIODA SANGOKUDO YAKUHIN CO., LTD.
  • Vaccine Safe Co
  • Vantage Oncology
  • Victoria Merger Sub, Inc.
  • Vitaco Holdings
  • Walgreen
  • Walgreens Boots Alliance
  • World Courier Group Inc.
  • Wyeth Pharmaceuticals
  • YAMAHIRO KURAYA SANSEIDO Inc.
  • Yunnan Pharmaceutical Co., Ltd.
  • Zuellig Pharma
Back to Top